Addressing current challenges in population health intervention research for health promotion.

Autor: Fillol A; University of Bordeaux, INSERM, BPH, U1219, Mérisp/PHARES Equipe Labellisée Ligue Contre le Cancer, Bordeaux, France.; CHU de Bordeaux, Service de prévention, Bordeaux, France.; University of Bordeaux, ISPED, Chaire Prévention, Bordeaux, France., Fonquerne L; Centre d'Epidémiologie et de Recherche en santé des POPulations (CERPOP) UMR1295, Equity team, Inserm, Université Toulouse III Paul Sabatier, Toulouse, France., Collange F; National Institute of Health and Medical (INSERM) CIC1408 Centre d'Investigation Clinique Saint-Etienne, Saint Etienne, France.; Presage Institute - Université Jean Monnet, Saint Etienne, France.; Laboratory P2S (Health Systemic Process), UR 4129, Faculty of Medicine Laennec, University Claude Bernard Lyon1, Lyon, France., Decroix C; University of Bordeaux, INSERM, BPH, U1219, Mérisp/PHARES Equipe Labellisée Ligue Contre le Cancer, Bordeaux, France.; CHU de Bordeaux, Service de prévention, Bordeaux, France.; University of Bordeaux, ISPED, Chaire Prévention, Bordeaux, France., Martin-Fernandez J; University of Bordeaux, INSERM, BPH, U1219, Mérisp/PHARES Equipe Labellisée Ligue Contre le Cancer, Bordeaux, France.; CHU de Bordeaux, Service de prévention, Bordeaux, France.; University of Bordeaux, ISPED, Chaire Prévention, Bordeaux, France., Aromatario O; University of Bordeaux, INSERM, BPH, U1219, Mérisp/PHARES Equipe Labellisée Ligue Contre le Cancer, Bordeaux, France.; CHU de Bordeaux, Service de prévention, Bordeaux, France.; University of Bordeaux, ISPED, Chaire Prévention, Bordeaux, France., Lamy S; Centre d'Epidémiologie et de Recherche en santé des POPulations (CERPOP) UMR1295, Equity team, Inserm, Université Toulouse III Paul Sabatier, Toulouse, France.; Tarn Cancer Registry, Claudius Regaud Institute, Toulouse, France.; Group for Research and Analyses in Public Health (GAP), Claudius Regaud Institute, IUCT-Oncopole, Toulouse, France., Delpierre C; Centre d'Epidémiologie et de Recherche en santé des POPulations (CERPOP) UMR1295, Equity team, Inserm, Université Toulouse III Paul Sabatier, Toulouse, France., Cousson-Gélie F; Université Paul-Valéry Montpellier 3, EPSYLON UR 4556, F34000, Montpellier, France.; Epidaure-Prevention Department of the Montpellier Cancer Institute, Montpellier, France., Cambon L; University of Bordeaux, INSERM, BPH, U1219, Mérisp/PHARES Equipe Labellisée Ligue Contre le Cancer, Bordeaux, France.; CHU de Bordeaux, Service de prévention, Bordeaux, France.; University of Bordeaux, ISPED, Chaire Prévention, Bordeaux, France.

Publikováno v: Global health promotion [Glob Health Promot] 2024 Nov 21, pp. 17579759241275139. Date of Electronic Publication: 2024 Nov 21.

Alos, N., Déziel, L., Di Liddo, L., Duclos, G., Fecteau, D., Lamy, S. et Rousseau, É. (2011). L’enfant, l’adolescent et le sport de compétition. Montréal, Québec : Éditions du CHU Sainte-Justine

Autor: Benjamin Hébert-Seropian

Publikováno v: Revue de psychoéducation. 44:469

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d7feb800209b9f0db238f2f874519f41
https://doi.org/10.7202/1039264ar

Cancer de la prostate : qualité de la prise en charge en Midi-Pyrénées en 2011

Autor: Daubisse-Marliac, L., Lamy, S., Lunardi, P., Tollon, C., Thoulouzan, M., Latorzeff, I., Bauvin, E., Grosclaude, P.

Publikováno v: In Progres en Urologie February 2017 27(2):68-79

The Influence of Sex and/or Gender on the Occurrence of Colorectal Cancer in the General Population in Developed Countries: A Scoping Review.

Autor: Martinez A; Equity Research Team, Centre d'Epidémiologie et de Recherche en santé des POPulations, UMR 1295 (Équipe Labellisée Ligue Contre le Cancer), Inserm, University Toulouse III Paul Sabatier, Toulouse, France.; Institut Universitaire du Cancer de Toulouse-Oncopole (Institut Claudius Regaud), Toulouse, France.; Registre des Cancers du Tarn, Toulouse, France., Grosclaude P; Institut Universitaire du Cancer de Toulouse-Oncopole (Institut Claudius Regaud), Toulouse, France.; Registre des Cancers du Tarn, Toulouse, France., Lamy S; Equity Research Team, Centre d'Epidémiologie et de Recherche en santé des POPulations, UMR 1295 (Équipe Labellisée Ligue Contre le Cancer), Inserm, University Toulouse III Paul Sabatier, Toulouse, France.; Institut Universitaire du Cancer de Toulouse-Oncopole (Institut Claudius Regaud), Toulouse, France.; Registre des Cancers du Tarn, Toulouse, France.; Equipe Labellisée Ligue Contre le Cancer, Toulouse, France., Delpierre C; Equity Research Team, Centre d'Epidémiologie et de Recherche en santé des POPulations, UMR 1295 (Équipe Labellisée Ligue Contre le Cancer), Inserm, University Toulouse III Paul Sabatier, Toulouse, France.; Institut Universitaire du Cancer de Toulouse-Oncopole (Institut Claudius Regaud), Toulouse, France.; Equipe Labellisée Ligue Contre le Cancer, Toulouse, France.

Publikováno v: International journal of public health [Int J Public Health] 2024 Apr 10; Vol. 69, pp. 1606736. Date of Electronic Publication: 2024 Apr 10 (Print Publication: 2024).

Increasing access to fertility preservation for women with breast cancer: protocol for a stepped-wedge cluster randomized trial in France.

Autor: Addamiano MC; EQUITY research team (Certified by the French League Against Cancer), CERPOP, UMR 1295, Université Toulouse III Paul Sabatier, Toulouse, France., Joannes C; EQUITY research team (Certified by the French League Against Cancer), CERPOP, UMR 1295, Université Toulouse III Paul Sabatier, Toulouse, France., Fonquerne L; EQUITY research team (Certified by the French League Against Cancer), CERPOP, UMR 1295, Université Toulouse III Paul Sabatier, Toulouse, France., Morel C; Regional Cancer Network of Occitanie (Onco-Occitanie), Toulouse, France., Lauzeille D; Regional Cancer Network of Pays de la Loire (Onco-PL), Nantes, France., Belkadi L; Regional Cancer Network of Occitanie (Onco-Occitanie), Toulouse, France., Empereur F; Regional Cancer Network of Pays de la Loire (Onco-PL), Nantes, France., Grosclaude P; EQUITY research team (Certified by the French League Against Cancer), CERPOP, UMR 1295, Université Toulouse III Paul Sabatier, Toulouse, France.; Tarn Cancers Registry, Claudius Regaud Institute, Toulouse University Cancer Institute (IUCT- O), Toulouse, France., Bauvin E; EQUITY research team (Certified by the French League Against Cancer), CERPOP, UMR 1295, Université Toulouse III Paul Sabatier, Toulouse, France.; Regional Cancer Network of Occitanie (Onco-Occitanie), Toulouse, France., Delpierre C; EQUITY research team (Certified by the French League Against Cancer), CERPOP, UMR 1295, Université Toulouse III Paul Sabatier, Toulouse, France., Lamy S; EQUITY research team (Certified by the French League Against Cancer), CERPOP, UMR 1295, Université Toulouse III Paul Sabatier, Toulouse, France.; Tarn Cancers Registry, Claudius Regaud Institute, Toulouse University Cancer Institute (IUCT- O), Toulouse, France., Durand MA; EQUITY research team (Certified by the French League Against Cancer), CERPOP, UMR 1295, Université Toulouse III Paul Sabatier, Toulouse, France. marie-anne.durand@dartmouth.edu.; The Dartmouth Institute for Health Policy & Clinical Practice, Dartmouth College, Lebanon, NH, USA. marie-anne.durand@dartmouth.edu.; Unisanté, University Center for General Medicine and Public Health, Lausanne, Switzerland. marie-anne.durand@dartmouth.edu.

Publikováno v: BMC public health [BMC Public Health] 2024 Jan 19; Vol. 24 (1), pp. 231. Date of Electronic Publication: 2024 Jan 19.